These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7780868)

  • 41. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of life after myocardial infarction: Canada versus the United States.
    Bassan M
    N Engl J Med; 1995 Feb; 332(7):469. PubMed ID: 7824021
    [No Abstract]   [Full Text] [Related]  

  • 43. Early management of ST-segment elevation myocardial infarction.
    Sura AC; Kelemen MD
    Cardiol Clin; 2006 Feb; 24(1):37-51. PubMed ID: 16326255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.
    Smith SC; Jackson R; Pearson TA; Fuster V; Yusuf S; Faergeman O; Wood DA; Alderman M; Horgan J; Home P; Hunn M; Grundy SM
    Circulation; 2004 Jun; 109(25):3112-21. PubMed ID: 15226228
    [No Abstract]   [Full Text] [Related]  

  • 45. Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry.
    Yan AT; Yan RT; Huynh T; Casanova A; Raimondo FE; Fitchett DH; Langer A; Goodman SG;
    Arch Intern Med; 2009 Feb; 169(4):372-8. PubMed ID: 19237721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction.
    Selmer R; Halvorsen S; Myhre KI; Wisløff TF; Kristiansen IS
    Scand Cardiovasc J; 2005 Oct; 39(5):276-85. PubMed ID: 16269397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Arterial hypertension and heart diseases. Diagnostic-therapeutic guidelines. Joint Commission of the National Association of Hospital Cardiologists, the Italian Society of Cardiology and the Italian Society of Arterial Hypertension].
    Agabiti-Rosei E; Giovannini E; Mancia G; Novo S; Pede S; Rappelli A; Sau F; Trevi G; Verdecchia P
    Cardiologia; 1999 Mar; 44(3):299-312. PubMed ID: 10327733
    [No Abstract]   [Full Text] [Related]  

  • 48. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rational diagnosis of acute myocardial infartion. Efficiency calculations].
    Grande P; Christiansen C; Pedersen A; Christensen MS
    Ugeskr Laeger; 1980 Jun; 142(24):1565-9. PubMed ID: 6774456
    [No Abstract]   [Full Text] [Related]  

  • 50. The effects of cardiac events on quality of life and indirect costs.
    Jönsson B; Buxton M; Kahan T; Poulter NR; Svarvar P;
    J Hum Hypertens; 2001 Aug; 15 Suppl 1():S91-3. PubMed ID: 11685921
    [No Abstract]   [Full Text] [Related]  

  • 51. A milestone for myocardial infarction.
    Wallace WA
    BMJ; 1988 Nov; 297(6657):1196. PubMed ID: 3144354
    [No Abstract]   [Full Text] [Related]  

  • 52. A Proposal for Modest Revision of the Definition of Type 1 and Type 2 Myocardial Infarction.
    de Lemos JA; Newby LK; Mills NL
    Circulation; 2019 Nov; 140(22):1773-1775. PubMed ID: 31765259
    [No Abstract]   [Full Text] [Related]  

  • 53. [The problem of associated diseases].
    Krylov AA
    Klin Med (Mosk); 1987 Dec; 65(12):3-9. PubMed ID: 3444304
    [No Abstract]   [Full Text] [Related]  

  • 54. One more look at guidelines for primary and secondary prevention of cardiovascular disease in women.
    Kolovou G; Marvaki A; Bilianou H
    Arch Med Sci; 2011 Oct; 7(5):747-55. PubMed ID: 22291817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comprehensive view of sex-specific issues related to cardiovascular disease.
    Pilote L; Dasgupta K; Guru V; Humphries KH; McGrath J; Norris C; Rabi D; Tremblay J; Alamian A; Barnett T; Cox J; Ghali WA; Grace S; Hamet P; Ho T; Kirkland S; Lambert M; Libersan D; O'Loughlin J; Paradis G; Petrovich M; Tagalakis V
    CMAJ; 2007 Mar; 176(6):S1-44. PubMed ID: 17353516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in five-year survival of patients discharged after acute myocardial infarction.
    Bata IR; Gregor RD; Wolf HK; Brownell B
    Can J Cardiol; 2006 Apr; 22(5):399-404. PubMed ID: 16639475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute myocardial infarction in Canada: improvement with time.
    Dodek A
    CMAJ; 2000 Jul; 163(1):41-2. PubMed ID: 10920730
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.
    Rochon PA; Anderson GM; Tu JV; Clark JP; Gurwitz JH; Szalai JP; Lau P
    CMAJ; 1999 Nov; 161(11):1403-8. PubMed ID: 10906894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment patterns of hypertension in 1996. Data from the Quebec Family Practice, University of Sherbrooke registry].
    Laplante P; Niyonsenga T; Delisle E; Vanasse N; Vanasse A; Grant AM; Xhignesse M
    Can Fam Physician; 1998 Feb; 44():306-12. PubMed ID: 9512834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
    Goa KL; Balfour JA; Zuanetti G
    Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.